2020. Phase 2 Study of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-Up. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s124. DOI:https://doi.org/10.25251/skin.4.supp.124.